Note: Ingredients listed on restricted chemical lists
EC/CAS
203-905-0/111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
≤5 <2.5
EC/CAS
231-944-3/7779-90-0
Name of the chemical
Trizinc bis(orthophosphate)
Concentration
<1
EC/CAS
203-542-8/108-01-0
Name of the chemical
2-dimethylaminoethanol
Concentration
≥5%
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
<0.0015 ≥0.0015%
General Information
Version
1.02
Revision date
2025-12-05
Product name
TEKNOCRYL AQUA 2935-20 - All variants
1.2.1 Relevant identified uses
Paint
Icons in SDS
Company Information
company name
Teknos Group Oy
e-mail address of the competent person responsible for the Safety Data Sheet
Prod-safe@teknos.com
GHS Information
Signal word
No signal word
Hazard Codes
Hazard statements (CLP)
H412
Hazard statements
Code
Statements
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
No signal word.
Hazard statements
H412 - Harmful to aquatic life with long lasting effects.
Prevention
P273 - Avoid release to the environment.
Response
Not applicable.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Contains
2,4,7,9-tetramethyl-5-decyne-4,7-diol, adipohydrazide and 2-methyl-2H- isothiazol-3-one. May produce an allergic reaction.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Aquatic Chronic 3, H412 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
